Stock Analysis on Net
Stock Analysis on Net
Microsoft Excel LibreOffice Calc

Boston Scientific Corp. (NYSE:BSX)

Paying users zone. Data is hidden behind: .

  • Get 1-month access to Boston Scientific Corp. for $13.99, or

  • get full access to the entire website for at least 3 months from $49.99.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey
Unlock

This is a one-time payment. There is no automatic renewal.

Cash Flow Statement
Quarterly Data

Beginner level

The cash flow statement provides information about a company’s cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company’s balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Boston Scientific Corp., consolidated cash flow statement (quarterly data)

US$ in millions

Microsoft Excel LibreOffice Calc
3 months ended: Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Cash provided by (used for) operating activities
Purchases of property, plant and equipment
Proceeds from sale of property, plant and equipment
Payments for acquisitions of businesses, net of cash acquired
Proceeds from royalty rights
Payments for investments and acquisitions of certain technologies
Proceeds from divestiture of certain businesses
Payments for settlements of hedge contracts
Proceeds from investments and collections of notes receivable
Cash used for investing activities
Payment of contingent consideration and royalty rights previously established in purchase accounting
Proceeds from royalty rights transfer
Payments on short-term borrowings
Proceeds from short-term borrowings, net of debt issuance costs
Net increase (decrease) in commercial paper
Payments on borrowings from credit facilities
Proceeds from borrowings on credit facilities
Payments on long-term borrowings and debt extinguishment costs
Proceeds from long-term borrowings, net of debt issuance costs
Cash used to net share settle employee equity awards
Proceeds from issuances of shares of common stock
Cash provided by (used for) financing activities
Effect of foreign exchange rates on cash
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents

Based on: 10-Q (filing date: 2020-05-06), 10-K (filing date: 2020-02-25), 10-Q (filing date: 2019-11-05), 10-Q (filing date: 2019-07-30), 10-Q (filing date: 2019-04-29), 10-K (filing date: 2019-02-19), 10-Q (filing date: 2018-10-29), 10-Q (filing date: 2018-07-31), 10-Q (filing date: 2018-05-01), 10-K (filing date: 2018-02-20), 10-Q (filing date: 2017-11-02), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-03), 10-K (filing date: 2017-02-23), 10-Q (filing date: 2016-11-03), 10-Q (filing date: 2016-08-03), 10-Q (filing date: 2016-05-04), 10-K (filing date: 2016-02-24), 10-Q (filing date: 2015-11-04), 10-Q (filing date: 2015-08-06), 10-Q (filing date: 2015-05-06).

Cash flow statement item Description The company
Cash provided by (used for) operating activities Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Boston Scientific Corp.’s cash provided by (used for) operating activities increased from Q3 2019 to Q4 2019 but then decreased significantly from Q4 2019 to Q1 2020.
Cash used for investing activities Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. Boston Scientific Corp.’s cash used for investing activities increased from Q3 2019 to Q4 2019 but then slightly decreased from Q4 2019 to Q1 2020.
Cash provided by (used for) financing activities Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. Boston Scientific Corp.’s cash provided by (used for) financing activities decreased from Q3 2019 to Q4 2019 but then slightly increased from Q4 2019 to Q1 2020.